Targeted therapy combination improves survival in patients with advanced bowel cancer

(European Society for Medical Oncology) New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer.

More From BioPortfolio on "Targeted therapy combination improves survival in patients with advanced bowel cancer"